← FDA DRUG APPROVALS

FDA NDA · NDA208870

DRAX EXAMETAZIME

kit for the preparation of technetium tc 99m exametazime for leukocyte labeling

Sponsor: JUBILANT

APPLICATION
NDA208870
TYPE
NDA
ORIGINAL APPROVAL
2017-08-17
LATEST ACTION
2017-08-17
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription

Products

DRAX EXAMETAZIMEPrescription
TECHNETIUM TC-99M EXAMETAZIME KIT N/A · POWDER · INTRAVENOUS

Approval history

2017-08-17Type 5 - New Formulation or New Manufacturer · Original · standard — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →